Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Malignant Melanoma

Free Subscription 19.07.2021 1 Br J Cancer 1 Br J Dermatol 3 J Am Acad Dermatol 1 J Clin Oncol 1 J Invest Dermatol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Br J Cancer

1. BOUCHEREAU S, Chaplain L, Fort M, Beauchet A, et al
   Impact of prior treatment with immune checkpoint inhibitors on dacarbazine efficacy in metastatic melanoma.
   Br J Cancer. 2021 Jul 14. pii: 10.1038/s41416-021-01486.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

2. STOER NC, Botteri E, Busund M, Ghiasvand R, et al
   Menopausal hormone therapy and risk of melanoma: a population-based cohort study.
   Br J Dermatol. 2021 Jul 13. doi: 10.1111/bjd.20640.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

3. BUI AN, Bougrine A, Buchbinder EI, Giobbie-Hurder A, et al
   Female sex is associated with higher rates of dermatologic adverse events among patients with melanoma receiving immune checkpoint inhibitor therapy: a retrospective cohort study.
   J Am Acad Dermatol. 2021 Jul 9. pii: S0190-9622(21)02087.
   PubMed        
   
   
4. STRAKER RJ 3RD, Thaler AS, Shannon AB, Miura JT, et al
   Acral lentiginous melanoma in the era of immune checkpoint blockade and targeted therapy: A National Cancer Database analysis.
   J Am Acad Dermatol. 2021 Jul 9. pii: S0190-9622(21)02095.
   PubMed        
   
   
5. KANTOR J
   August 2021: On the epistemology of Breslow thickness and histopathologic melanoma subtype.
   J Am Acad Dermatol. 2021;85:318.
   PubMed        
   
   

   
   J Clin Oncol

6. DIAB A, Tykodi SS, Daniels GA, Maio M, et al
   Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma.
   J Clin Oncol. 2021 Jul 13:JCO2100675. doi: 10.1200/JCO.21.00675.
   PubMed         Abstract available
   
   

   
   J Invest Dermatol

7. QUADRI M, Comitato A, Palazzo E, Tiso N, et al
   Activation of PKG restricts melanoma growth and invasion by interfering with the EGF/EGFR pathway.
   J Invest Dermatol. 2021 Jul 12. pii: S0022-202X(21)01420.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: